一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Frontiers in Immunology >>article
Frontiers in Immunology

Frontiers in Immunology

IF: 5.7
Download PDF

HIV subtype-specific gp140-CD4 binding, Temsavir efficacy, and identification of novel adhesion inhibitors against Chinese HIV strains

Published:22 September 2025 DOI: 10.3389/fimmu.2025.1648546 PMID: 41058708
Tianyang Liu,?Xiaowen Li,?Xiaolin Yang,?Shengjie Zhang,?Yao Wang,?Siwei Zhang,?Lin Cheng,?Shanshan Tang,?Fuxiang Wang,?Yao Zhao,?Hongzhou Lu,?Lanlan Wei

Abstract

Introduction: The HIV epidemic in China is characterized by significant genetic diversity with multiple circulating recombinant forms (CRFs). The gp120-CD4 interaction, essential for viral cellular entry, exhibits subtype-dependent structural variations that compromise therapeutic efficacy. Although temsavir remains the only FDA-approved adhesion inhibitor, its activity against predominant HIV subtypes in China has not been systematically evaluated.

Methods: HIV subtyping of 472 clinical samples identified five major strains (B, CRF01_AE, CRF07_BC, CRF08_BC, and CRF55_01B). Recombinant gp140 proteins from these subtypes were expressed, purified, and analyzed via bio-layer interferometry (BLI) to characterize CD4 binding properties. Structural analyses compared hydrogen bonding and interface buried surface areas. Temsavir's inhibitory efficacy was assessed, and virtual screening of 13,819 compounds combined with BLI validation was performed to identify novel inhibitors.

Results: Subtype B demonstrated the strongest CD4 binding affinity (KD=79 pM), while CRF55_01Bshowed the weakest binding (KD=8.76 nM). CRF variants exhibited reduced hydrogen bonding and smaller interface buried surface areas, correlating with diminished binding affinity. Temsavir inhibition was subtype-dependent, achieving 35.7% inhibition for subtype B versus <1.3% for CRF01_AE and CRF55_01B, primarily due to steric hindrance induced by the S375H mutation. Five novel inhibitors targeting CRF55_01B were identified with inhibition rates 19%.

Discussion: This study elucidates the molecular mechanisms of HIV-1 adhesion variation and provides specific candidate HIV adhesion inhibitors for prevalent CRF subtypes in China. Subsequent efforts will focus on preclinical validation and structure-activity relationship optimization of these candidates, laying the groundwork for developing personalized therapeutic strategies against region-specific strains.

Substances (40)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Risedronic acid 105462-24-6 C7H11NO7P2 345 suppliers $7.00-$1504.50
Risedronic acid 105462-24-6 C7H11NO7P2 345 suppliers $7.00-$1504.50
Risedronic acid 105462-24-6 C7H11NO7P2 345 suppliers $7.00-$1504.50
Risedronic acid 105462-24-6 C7H11NO7P2 345 suppliers $7.00-$1504.50
Zoledronic acid hydrate 165800-06-6 C5H12N2O8P2 317 suppliers $6.00-$729.00
Zoledronic acid hydrate 165800-06-6 C5H12N2O8P2 317 suppliers $6.00-$729.00
Zoledronic acid hydrate 165800-06-6 C5H12N2O8P2 317 suppliers $6.00-$729.00
Zoledronic acid hydrate 165800-06-6 C5H12N2O8P2 317 suppliers $6.00-$729.00
L-KYNURENINE 2922-83-0 C10H12N2O3 286 suppliers $23.00-$2096.24
L-KYNURENINE 2922-83-0 C10H12N2O3 286 suppliers $23.00-$2096.24

Similar articles

IF:4.3

Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.

ACS Applied Electronic Materials Christopher J De Feo, Carol D Weiss,etc Published: 1 December 2012
IF:96.2

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection.

New England Journal of Medicine M Markowitz, M Saag,etc Published: 7 December 1995
IF:13

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Drugs Risto S Cvetkovic, Karen L Goa,etc Published: 1 January 2003
高安市| 崇仁县| 新兴县| 固原市| 克拉玛依市| 乌什县| 屯昌县| 漳州市| 辽宁省| 贡嘎县| 丰城市| 宝鸡市| 胶州市| 沭阳县| 曲沃县| 大渡口区| 普兰店市| 玉田县| 罗山县| 博湖县| 望奎县| 平安县| 如皋市| 隆安县| 安康市| 铜鼓县| 北海市| 水富县| 吉木乃县| 东乡县| 荆州市| 天柱县| 阿坝| 长沙市| 丰都县| 扶风县| 白水县| 锦州市| 孙吴县| 罗山县| 焦作市|